key: cord-0951180-i1iwn2qd
authors: Alkhatip, Ahmed Abdelaal Ahmed Mahmoud M.; Kamel, Mohamed Gomaa; Hamza, Mohamed Khaled; Farag, Ehab Mohamed; Yassin, Hany Mahmoud; Elayashy, Mohamed; Naguib, Amr Ahmed; Wagih, Mohamed; Abd-Elhay, Fatma Abd-Elshahed; Algameel, Haytham Zien; Yousef, Mohammed A.; Purcell, Andrew; Helmy, Mohamed
title: The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis
date: 2021-04-10
journal: Expert review of molecular diagnostics
DOI: 10.1080/14737159.2021.1915773
sha: fda7785debf6f5c98f5f16ac610ba24ce2173334
doc_id: 951180
cord_uid: i1iwn2qd

Background: The world urgently requires surrogate markers to diagnose COVID-19 and predict its progression. The severity is not easily predicted via currently used biomarkers. Critical COVID‐19 patients need to be screened for hyperinflammation to improve mortality but expensive cytokine measurement is not routinely conducted in most laboratories. The neutrophil-to-lymphocyte ratio (NLR) is a novel biomarker in patients with various diseases. We evaluated the diagnostic and prognostic accuracy of the NLR in COVID-19 patients. Methods: We searched for relevant articles in seven databases. The quantitative analysis was conducted if at least two studies were evaluating the NLR role in COVID-19. Results: We included 8,120 individuals, including 7,482 COVID-19 patients, from 32 articles. Patients with COVID-19 had significantly higher levels of NLR compared to negative individuals. Advanced COVID-19 stages had significantly higher levels of NLR than earlier stages. Expert Opinion: We found significantly higher levels of NLR in advanced stages compared to earlier stages of COVID-19 with good accuracy to diagnose and predict the disease outcome, especially mortality prediction. A close evaluation of critical SARS-CoV-2 patients and efficient early management are essential measures to decrease mortality. NLR could help in assessing the resource allocation in severe COVID-19 patients even in restricted settings.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2, a.k. a. COVID-19) is now much more hazardous than previously thought when compared to other viral pandemics. The H1N1 pandemic outbreak of 2009 caused 12,429 deaths over a year while the SARS-CoV-2 outbreak resulted in >13,000 over 5 weeks in the USA alone [1] . SARS-CoV-2 may present as a mild disease with interstitial and alveolar pneumonia; however, it can affect other organs, such as the kidneys, heart, digestive tract, and nervous system [2] [3] [4] [5] . There are no specific antiviral therapies or vaccines for COVID-19 patients. Consequently, researchers started to use clinically accessible interventions utilized previously during SARS-CoV and the Middle East respiratory syndrome-coronavirus (MERS-CoV) outbreaks due to their genetic and clinical similarities [6] .

Because of the rapid spread of the pandemic, the world urgently requires surrogate markers to diagnose COVID-19 infection. Perhaps as importantly, markers that help predict disease progression and severity are needed to help identify high-risk individuals in efforts to ensure optimal resource allocation in a time of significant resource demand. Effective predictors could also help screening, clinical management, and prevention of fatal sequelae. Indeed, critical COVID-19 status is not easily predicted via routinely used laboratory parameters including levels of platelets, eosinophil, hemoglobin, D-dimer, IL-6, lactate dehydrogenase, prothrombin time, activated partial thromboplastin time and transaminases [7] [8] [9] [10] [11] [12] . Further, patients with severe COVID-19 infection need to be screened for hyper-inflammatory status using laboratory biomarkers in efforts to improve morbidity and mortality since numerous studies suggest that a subgroup of critical COVID-19 infected patients could have immune dysregulation potentially contributing to the development of a virally induced hyper-inflammatory state [13] . Expensive cytokine profile measurement is not routinely performed in most laboratories and is needed to identify patients who would potentially benefit from anti-IL6 immunotherapies with tocilizumab [7] . In contrast, routine full blood count and white cell differentials are readily available and performed across the vast majority of healthcare settings caring for COVID-19 infected patients. Therefore, reliable markers of infection such as neutrophilto-lymphocyte ratio (NLR), associated with IL-6, could be considered valuable in efforts to help diagnosis and prognosis.

The NLR, an inflammatory index reflecting systemic inflammatory cascades, is a novel biomarker in patients with pneumonia, various cardiovascular diseases, sepsis, multiple organ damage, cancer, and pregnancy complications [14] [15] [16] [17] [18] [19] [20] [21] . Accumulated evidence has shed light on the pivotal diagnostic and prognostic role of NLR in infections. Han and coworkers demonstrated that NLR had better accuracy compared to the total leukocyte count, neutrophil or lymphocyte count and is used as an efficient diagnostic measure to screen individuals infected with influenza virus [22] because it is less influenced by physiological interference such as that seen with dehydration or physical activity. In addition, NLR has been measured and used to forecast recurrence in those with hepatitis B [23] . A comprehensive analysis of all published studies has not been conducted yet to investigate the estimated accuracy of NLR in the context of COVID-19 infections although several studies revealed its findings from routine blood tests in severe and non-severe COVID-19 patients. With this in mind, this systematic review and meta-analysis aimed to investigate the diagnostic and prognostic accuracy of the NLR in COVID-19 patients.

This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Supplemental File 1) [24] . The protocol was registered on the International Prospective Register of Systematic Reviews PROSPERO (CRD42020201117). In July 2020, we conducted an electronic search to acquire pertinent studies on the following databases; PubMed, Embase, Institute of Science Index, Scopus, and Cochrane Central Register of Controlled Trials (CENTRAL). Prespecified search terms were utilized and adapted to each database to yield the most accurate results (Supplementary File 2). Moreover, the references from relevant studies and previous reviews were manually searched. Furthermore, Chinese databases such as Wanfang as well as China National Knowledge Infrastructure databases were searched. Three reviewers independently screened titles and abstracts according to our inclusion and exclusion criteria and any disagreements were resolved through discussion.

The inclusion criteria were studies investigating the diagnostic and/ or prognostic role of NLR in COVID-19 patients against the reference standard (polymerase chain reaction (PCR) test). Any original studies including clinical trials and observational studies with no restrictions regarding language, race, sex, country, year, and age were included. Our exclusion criteria were overlapped data sets and duplicated studies. Articles such as animal studies, case reports, previous reviews, conference, books, or thesis or author responses which do not have enough information to be extracted were excluded. Included studies were required to have a two-bytwo table for the analysis constructed from the reported information, raw data, or sensitivity, and specificity of the NLR. We contacted the authors if these values were not reported. All full texts were reviewed carefully by three independent reviewers and where there was any disagreement it was resolved through discussion to reach a final decision.

A standardized data extraction sheet was produced in Microsoft Excel. The data were extracted by three independent authors. The discussion was held if there were any disagreements. Conclusions were drawn with the consensus of the three authors or, if needed, discussed with a fourth author. Papers published by the same research group and/or studying the same outcomes were examined for potential duplicate information based on the month and year of patients' recruitment and hospital where the patients were recruited and confirmation from authors of the study. The extracted information included the authors' names, study design, year, number of patients, hospital, and country. Moreover, patients' demographics (such as age and gender), the cutoff value of NLR and the definition of the different groups such as severe COVID-19 patients were extracted.

Our primary outcome was to determine the diagnostic and/ or prognostic accuracy of NLR in COVID-19 patients whereas our secondary outcome was to compare the values of NLR in different groups (control individuals versus mild, moderate, severe, and lethal COVID-19 infections).

We used the quality assessment of diagnostic accuracy studies (QUADAS-2) method. The QUADAS-2 evaluates four items for bias and applicability of the research question including patients' selection, index test, reference standard, and flow and timing [25] . The quality of the included studies was evaluated by three authors independently and if any disagreement occurred, it was resolved through discussion.

The quantitative analysis was conducted if at least two studies were evaluating the role of NLR in COVID-19 diagnosis and prognosis. The accuracy measures included the sensitivity, specificity, likelihood ratios, and diagnostic odds ratio (DOR) with their 95% confidence intervals (CIs). A higher DOR indicates a higher diagnostic accuracy. AUC values of ≥0.5, 0.75, 0.93, or 0.97 were considered to represent fair, good, very good, or excellent accuracy, respectively [26, 27] . Moreover, we also constructed a hierarchical summary receiver operator curve (SROC). We used mean difference (MD) to compare values of NLR across different groups. A fixed-effect method [28] was applied when there was no evidence of heterogeneity between studies, otherwise, a random-effects method was chosen [29, 30] . The heterogeneity between studies was evaluated using Q statistic and I 2 test [29, 31, 32] ; where P-value = 0.1 and/or I 2 > 50% indicating a significant heterogeneity [33, 34] . The heterogeneity was explored using meta-regression, and sensitivity as well as subgroup analysis according to the potential covariates such as study design, risk of bias, percentage of the event (such as severe or lethal cases of COVID-19 infection), males' per cent, the cutoff value of the NLR. The meta-regression has been used to explore between-study heterogeneity in meta-analysis studies aiming to incorporate the effect of the aforementioned covariates on summary measures of performance. Since the publication bias analysis is a concern for meta-analysis, it was conducted using the funnel plot and the Egger test [35] . We used the Midas command in Stata software version 12 [36] and Comprehensive Meta-analysis (CMA) software version 3 (Biostat, NJ, USA) for the analysis. A P-value <0.05 was considered significant.

Our search retrieved 291 articles, among which 74 duplicates were removed. The rest underwent abstract screening to yield 92 articles for full-text screening. Ultimately, a total of 32 articles with 8,120 individuals, including 7,482 COVID-19 patients, were included. Three articles were investigating the role of NLR in COVID-19 diagnosis, 2 in diagnosis and severity, 17 in severity, 4 in severity and mortality, 6 in mortality prediction only (Figure 1 ).

There were 28 retrospective articles with a male percentage ranging from 37.3 to 69% with only one study including only females, and mean age ranging from 28.4 to 65 years (Table 1) . All studies used PCR as an inclusion criterion except for Pascual Gómez et al. who had 74.2% of the patients as positive SARS-CoV-2 cases by PCR [37] . 

Of the included articles, 27 were at low risk of bias, while only 5 were at high risk of bias (Table S2 ). 

Moderate and severe COVID-19 infected patients had significantly higher levels of NLR than mild and non-severely infected patients, (MD 

Our sensitivity analysis, through removing one study each time, did not alter the results (Table 3) . Of note, we used subgroup analysis and meta-regression to see the effect of covariates and heterogeneity on the accuracy of the NLR in diagnosis and prediction. It is worth mentioning that heterogeneity was found. However, setting the cutoff value of NLR to ≥3. 63 

In this study, we found significantly higher levels of NLR in advanced stages compared to earlier stages of COVID-19 with good accuracy to diagnose and predict the disease, especially to predict mortality from COVID-19. COVID-19 diagnosis relies primarily on SARS-CoV-2 detection via PCR. Yet, there are still numerous drawbacks including falsenegative findings due to a low viral load and the relative shortage of detection kits [65] . A test with the ability to discern quickly and early COVID-19 is needed as a biomarker to help predict and prevent associated morbidity and mortality. It was also suggested that routine blood tests were more acceptable for screening individuals with asymptomatic or mild COVID-19 and may be used for screening in outbreak areas [66] . NLR is readily calculated and cost-effective such that clinicians can screen high-risk individuals earlier. This is especially desirable in settings experiencing healthcare resource scarcity. It was stated that the NLR was the most helpful independent prognostic biomarker in determining the COVID-19 prognosis and the treatment efficacy [13, 22, [67] [68] [69] [70] . Besides, NLR had a higher diagnostic accuracy than other assessment tools such as the CURB-65 and MuLBSTA scores [67] . It was demonstrated that procalcitonin does not enable clinicians to immediately decide if the infection is viral or bacterial and consequently if antibiotics are better to be administered or withheld [71] . Yet, the NLR is better compared to inflammatory markers including c-reactive protein or interleukin [13] .

Acute respiratory distress syndrome (ARDS), featured by a rapid onset of generalized pulmonary inflammation, is the leading cause of death in SARS-CoV-2 patients. With this, elevated NLR reflecting an enhanced inflammation may suggest a poorer prognosis compared to those with lower NLR. Additionally, individuals with serious viral infection could have a bacterial co-infection due to their low immune response, resulting in an increased NLR [72] . The NLR elevation could occur due to dysregulation of inflammatory cytokine expression, an aberrant increase of pathological low-density neutrophils and up-regulation of genes involved in lymphocytic apoptosis [73] [74] [75] . Lymphocytes also are depleted as the virus is engulfed. Recent studies reported that the COVID-19 may primarily affect T-cells (particularly CD4+ and CD8 + T-cells) [76] but not absolute B-cell and natural killer (NK) cells [77] . The virus' ability to infect T-cells through ACE-2 receptors and cluster of differentiation (CD)147-spike proteins is another mechanism [78] . The inflammatory response may trigger hyper-secretion of inflammatory cytokines including TNF-α and IL-6, leading to permanently high neutrophils. In contrast, catecholamines, cortisol, and the increased pro-inflammatory mediators will bind to lymphocytic surface receptors and subsequently initiate lymphocytic apoptosis, leading to lymphopenia [79] , and clinical deterioration in COVID-19. The rise of pro-inflammatory cytokines with lymphopenia predisposes severe COVID-19 patients to cytokine storm, thus leading to more lymphocytic apoptosis and multi-organ failure [13, 67, 80, 81] .

The severity of pathologic injury during SARS or MERS correlates with the extensive infiltration of neutrophils in the lung and increased neutrophils in the peripheral blood [82] . The extent of the increased neutrophils could therefore suggest the intensity of inflammatory responses in COVID-19. Bearing both of these issues in mind, the NLR may serve as a useful factor to reflect the intensity of imbalance of inflammation and immune responses in COVID-19, particularly seeing as how it drops upon improvement of the clinical condition [66, 83] .

Growing evidence has revealed that neutrophils exhibit both pathological and protective functions [84] . Neutrophil survival may be prolonged for several days after viral infection [85] . The prolonged activation of neutrophils leads to the production of pro-inflammatory mediators and toxins, which are harmful to cells [86, 87] . Neutrophils constitute the nonspecific immunity that initiates the body's responses to inflammation, whereas lymphocytes constitute the protective element against inflammation, indicate the extent of immune system impairment and are important for dampening overactive innate immune responses during viral infection [88] . Thus, lymphopenia may result in aggravated inflammatory processes while restoration of T-lymphocytes may alleviate them. Some studies have suggested that lymphopenia indicates that SARS-CoV-2 consumes many immune cells, inhibits the cellular immune function, and results in a reduced but hyper-activated peripheral T -lymphocytes; actions that partially account for the severe immune injury in COVID-19 62 .

Of note, we included missing data given by included article's authors, conducted risk of bias evaluation, and provided sensitivity analysis by removing articles with a high risk of bias.

Our results are robust because our findings were the same in nearly all sensitivity and subgroup analyses where exclusion of studies with a poor QUADAS-2 assessment or a study with negative PCR for some of the included patients did not alter the conclusions [37] . Our analysis is however not without some limitations. The effect of heterogeneity may be low because most of the studies were in China. Additionally, it was unclear when in the disease course the NLR values were measured; depending on the severity of COVID-19 infection, NLR values may change during the disease course. Although the NLR had high accuracy, no unified cutoff is present, and its accuracy can be influenced by clinician experience. With this in mind, due diligence should be made while interpreting NLR findings in this context.

Laboratory biomarkers to forecast the severity of COVID-19 are essential in a pandemic because resource allocation must be carefully planned. NLR could help in assessing the allocation of respiratory equipment in ICU patients and early evaluation for those in need of ECMO. The close evaluation of COVID-19 severity and effective early interventions are key measures to reduce mortality. Indeed, it is strongly recommended that physicians should use a combination of readily available biomarkers to better diagnose and/or predict COVID-19 than depending on a single test. A prospective data collection Author, year, country Study design Sample size COVID-19 Cases/Severe/Died Age, years* Male, % Risk of bias # Anggraini, 2020, Indonesia [66] Cross-sectional*** [38] *** 9 9/NR/0 28.44 0 Low Asghar, 2020, Pakistan [39] Retrospective 100 100/33/22 52.58 69 High Chen, 2020, China [40] Retrospective 681 681/681/104 65 53.2 Low Cheng, 2020, China [41] Retrospective 456 456/251/46 54.97 46.27 Low Hongbing, 2020, China [42] Retrospective 93 93/43/31 62.07 59.1 Low Huang, 2020, China [43] Retrospective 415 415/29/NR 44 52.3 Low Huang, 2020, China [44] Retrospective 344 344/45/15 52.9 54.7 Low Hui, 2020, China [45] Retrospective 84 84/NR/42 66.5 66.7 Low Liu, 2020, China [67] Prospective 115 115/37/0 42.5** 55.7 Low Liu, 2020, China [77] Retrospective 40 40/13/3 48.7 37.5 Low Liu, 2020, China [46] Retrospective 84 84/43/3 53 56 Low Liu, 2020, China [47] Retrospective 134 134/19/0 51.5 47 High Long, 2020, China [70] Prospective 301 301/66/17 51 49.8 Low Shi, 2020, China [48] Retrospective 723 696/63/NR 45.27 52.1 Low Mingming, 2020, China [49] Retrospective 72 72/20/NR 58.01 44.4 Low Nalbant, 2020, Turkey [50] Retrospective 80 54/NR/NR 55.3 51 Low Ok, 2020, Turkey [51] Retrospective 139 139/54/13 55.5 44.6 Low Pascual Gómez, 2020, Spain [37] Retrospective 163 163/NR/33 64.75 49.7 High Peng, 2020, China [52] Retrospective 485 190/31/NR 46.64 48.7 Low Rocio, 2020, Spain [53] Prospective 501 501/42/36 52 63.3 High Shang, 2020, China [54] Retrospective 443 443/139/NR 56 49.7 Low Sun, 2020, China [55] Retrospective 116 116/27/NR 54.5** 51.7 Low Tan, 2020, China [56] Retrospective 102 27/6/two 39.2** 37.3 Low Tatum, 2020, USA [57] Retrospective with a multi-variable prediction model is required to derive a robust score for COVID-19 diagnosis and prediction.

We would like to thank all authors of the included studies who helped us in this study by providing us with the missing raw data that allowed us to complete the analysis and make the study more rigorous. Prospero Registration ID: CRD42020201117.

• Question: What is the diagnostic and prognostic accuracy of neutrophil-to-lymphocyte ratio (NLR) in COVID-19?

• Finding: We found significantly higher levels of NLR in advanced stages compared to earlier stages of COVID-19 with good accuracy to diagnose and predict the disease, especially to predict the mortality from COVID-19.

• Meaning: NLR could help in assessing the resource allocation in severe COVID-19 patients even in restricted settings.

This paper was not funded.

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

The dataset supporting the conclusions of this article is included within the article (and its additional files).

AAAMMA: this author helped in developing the idea, designing the study, writing the protocol, searching the databases, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

MGK: this author helped in developing the idea, designing the study, writing the protocol, searching the databases, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

MKH: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

EMF: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

HMY: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version. ME: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

AAN: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

MW: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

FAA: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

HZA: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

MAY: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

AP: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version. Abbreviations; CI = confidence interval, DOR = diagnostic odds ratio, LR = likelihood ratio. MH: this author helped in writing the protocol, screening, data extraction, writing, and reviewing the manuscript and approving the final version.

Supplemental data for this article can be accessed here. 

H1N1 Pandemic (H1N1pdm09 virus) | Pandemic Influenza (Flu) | CDC

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

First case of focal epilepsy associated with SARS-coronavirus-2

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Epidemiologic features and clinical course of covid-19: a retrospective analysis of 19 patients in Germany

Possible therapeutic agents for COVID-19: a comprehensive review

The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Biochemical biomarkers alterations in coronavirus disease 2019 (COVID-19). Diagnosis

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

Biomarkers associated with COVID-19 disease progression

Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

The clinical utility of neutrophil to lymphocyte ratio in pregnancy related complications: a mini-review

Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department

Neutrophil to lymphocyte ratio and cardiovascular diseases: a review

Evaluation of complete blood count parameters in cardiovascular diseases: an early indicator of prognosis?

Prognostic value of neutrophil-tolymphocyte ratio in sepsis: a meta-analysis

Added value of inflammatory markers to vital signs to predict mortality in patients suspected of severe infection

The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis

Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms

Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests

The diagnostic accuracy of noninvasive methods to measure the intracranial pressure: a systematic review and meta-analysis

Statistical aspects of the analysis of data from retrospective studies of disease

Meta-analysis in clinical trials

Deep hypothermic circulatory arrest in the pediatric population undergoing cardiac surgery with electroencephalography monitoring: a systematic review and meta-analysis

Measuring inconsistency in meta-analyses

Mast cell mediators in relation to dengue severity: a systematic review and meta-analysis

Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches

Meta-analysis of genetic association studies

Bias in meta-analysis detected by a simple, graphical test

midas: meta-analysis of diagnostic accuracy studies

Potential biomarkers predictors of mortality in COVID-19 patients in the emergency department. Revista espanola de quimioterapia: publicacion oficial de la Sociedad Espanola de Quimioterapia

T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV

Clinical profiles, characteristics, and outcomes of the first 100 admitted COVID-19 patients in pakistan: a single-center retrospective study in a tertiary care hospital of karachi

The characteristics and outcomes of 681 severe cases with COVID-19 in China

Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort

Biochemical analysis between common type and critical type of COVID-19 and clinical value of neutrophil/ lymphocyte ratio

Significance of neutrophil-tolymphocyte ratio, platelet-to-lymphocyte ratio for predicting clinical outcomes in COVID-19

Individualized prediction nomograms for disease progression in mild COVID-19

Predictive value of multiple inflammatory indexes on the prognosis of patients with corona virus disease 2019

Combined use of the neutrophil-tolymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study

CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients

Predictive value of the neutrophil-tolymphocyte ratio (nlr) for diagnosis and worse clinical course of the COVID-19: findings from ten provinces in China

Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019

Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)? Revista da

Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients

Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): a multicenter, cross-sectional study

Interleukin-6-based mortality risk model for hospitalised COVID-19 patients

The value of clinical parameters in predicting the severity of COVID-19

Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China

C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early

Neutrophil-to-lymphocyte ratio and outcomes in louisiana covid-19 patients

Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters

Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019

The role of peripheral blood eosinophil counts in COVID-19 patients

Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross-sectional study

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients

An emerging marker predicting the severity of COVID-19: neutrophil-lymphocyte count ratio

Neutrophil-to-lymphocyte ratio may replace chest computed tomography to reflect the degree of lung injury in patients with corona virus disease 2019 (COVID-19)

COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients

Low neutrophil-to-lmphocyte ratio decreases risk of coronavirus disease in pregnant women

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19

An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19. Nan fang yi ke da xue xue bao=

Short-term outcomes of COVID-19 and risk factors for progression

Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Longitudinal peripheral blood transcriptional analysis of COVID-19 patients captures disease progression and reveals potential biomarkers

Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome

Immune-epidemiological parameters of the novel coronavirus-a perspective

Clinical and immunologic features in severe and moderate forms of coronavirus disease

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic

Clinical and immunological features of severe and moderate coronavirus disease 2019

CoV-2: a storm is raging

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Paper presented at: Seminars in immuno pathology2017

Clinical course of coronavirus disease-2019 (COVID-19) in pregnancy

Neutrophil in viral infections, friend or foe?

Contribution of neutrophils to acute lung injury

The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice

Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice

Adaptive immune cells temper initial innate responses